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Prostaglandin synthesis inhibition during volume expansion: Collecting
duct function. The aim of this study was to examine the possible role of
renal prostaglandins in the response of the inner medullary collecting
duct (IMCD) to acute volume expansion. Collecting duct microcathe-
terization and clearance studies were carried out in anesthetized rats,
volume-expanded with isotonic Ringer's solution. In volume-expanded
control animals, there was no significant sodium or chloride reabsorp-
tion between the beginning and end (papillary tip) of the IMCD.
Administration of indomethacin or meclofenamate prior to and during
volume expansion in two other groups of rats resulted in significant
water, sodium, and chloride reabsorption along the IMCD and marked-
ly blunted the diuretic, natriuretic and chloriuretic response to volume
expansion. Because delivery to the beginning of the duct was not
significantly decreased, enhanced reabsorption in the IMCD largely
accounted for the decrease in natriuresis and chioriuresis. Inner medol-
lary tissue fluid chloride concentration increased after inhibition of
prostaglandin synthesis. The results indicate that renal prostaglandins,
perhaps by directly decreasing sodium chloride reabsorption, have an
important role in the decrease in collecting duct reabsorption of sodium
and chloride observed with acute volume expansion.
L'inhibition de Ia synthèse des prostaglandines pendant une expansion
volémique: La fonction du tubule collecteur. Le but de cette etude a été
d'évaluer le role possible des prostaglandines rénales dans Ia reponse
do tube collecteur médullaire interne (IMCD) a une expansion volém-
ique aiguë. Une microcathétérisation des tubes collecteurs et des etudes
de clairance ont été faites chez des rats anesthesiés, en expansion
volemique par de Ia solution de Ringer isotonique. Chez les animaux
contrOles en expansion volemique, ii n'y avait pas de reabsorption
significative du sodium ou du chlore entre le debut et Ia fin (pointe de Ia
papille) de l'IMCD. L'administration d'indomethacine ou de méclofen-
amate avant et pendant one expansion volemique chez deux autres
groupes de rats a entrainé une reabsorption significative d'eau, de
sodium et de chlore Ic long de l'IMCD et a inhibé de facon marquee Ia
réponse diuretique, natriurétique et chloruretique a l'expansion volCm-
ique. Parce qu'il n'y avait pas de diminution significative des sub-
stances délivrées a l'entrée du tube, l'augmentation de Ia reabsorption
dans l'IMCD expliqoait en grande partie Ia diminution de Ia natriurCse
et de Ia chlorurèse. La concentration en chlore do liquide tissulaire de la
médullaire interne s'est accrue après inhibition de Ia synthèse des
prostaglandines. Ces résultats indiquent que les prostaglandines rénales
ont on role important dans Ia diminution de la reabsorption do sodium et
do chlore dans Ic tube collecteur observe apres one expansion volém-
iqoe aiguë, peot-être en diminuant directement Ia reabsorption de
sodium chlore.
Recent evidence indicates that the terminal nephron seg-
ments (cortical and medullary collecting tubules) play a major
role in regulating the natriuretic response to acute volume
expansion [1—4]. The mechanisms involved in the response of
the terminal nephron to volume expansion are unknown. The
aims of this study were to observe the role of prostaglandins in
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the renal response to volume expansion and to further localize
the site of regulation by using microcatheterization to determine
reabsorption along the length of the medullary collecting duct.
Previous microcatheterization studies show that water, sodi-
um [2, 5, 61, and chloride [6] reabsorption are inhibited in the
medullary collecting duct during volume expansion. Micro-
puncture studies, on the other hand, indicate that the remaining
fraction of filtered sodium chloride increases between the
surface distal tubule and papillary collecting duct and attribute
this change to selective inhibition of reabsorption in the juxta-
medullary nephrons during volume expansion with reabsorp-
tion persisting in the papillary portion of the collecting duct [3,
4, 7, 8]. Despite these differences, there is agreement that
decreased reabsorption of sodium and water between the
surface distal tubules and final urine is critical in the renal
response to volume expansion.
Evidence for a possible role for prostaglandins in the renal
response to volume expansion was obtained by Higashihara et
al [8], who demonstrated that inhibition of renal prostaglandin
synthesis with meclofenamate or indomethacin blunted the
chloriuretic response to acute volume expansion by increasing
chloride reabsorption in the superficial loop of Henle and in
nephron segments between the superficial late distal tubule and
the base of the papillary collecting duct. Increased reabsorption
between the distal tubule and the papillary base could result
from changes in juxtamedullary nephron and/or cortical or
medullary collecting duct function. In this study, indomethacin
or meclofenamate markedly blunted the natriuretic and chlor-
iuretic response to acute volume expansion; this effect was
largely the result of increased sodium and chloride reabsorption
in the inner medullary collecting duct (IMCD). These results
imply that enhanced prostaglandin synthesis, through inhibition
of collecting duct sodium chloride reabsorption, is of major
importance in the response of the kidney to acute volume
expansion.
Methods
Three groups of male Sprague-Dawley rats, weighing from
275 to 325 g, were used for clearance and collecting duct
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microcatheterization experiments. All rats were allowed free
access to food and water except that food was limited the night
prior to the experiment. Collecting duct microcatheterization
experiments and clearances were carried out as previously
described [2, 5]. Rats were anesthetized with mactin (100 mg/kg
body wt i.p.), and body temperature was kept at 37 to 38° C on a
heated operating table. Tracheostomies were performed on the
rats. A jugular vein and femoral artery were cannulated
for infusion and for blood pressure measurement and sam-
pling, respectively. From the start of surgery, isotonic Ringer's
solution (sodium = 140, chloride = 115, bicarbonate = 30,
potassium = 5 mEq/liter) was given by a constant intra-
venous infusion at 1.5 mI/hr. The left kidney was prepared
for microcatheterization and urine collection. 3H-inulin
was added to the constant infusion to deliver 167 Ci of isotope
over the course of the experiment. After completing the sur-
gery, volume expansion with Ringer's bicarbonate solution was
carried out by administering 24 ml i.v. over 60 mm; the infusion
rate was then maintained at 12 mI/hr. Collecting duct sampling
was begun after the first hour of volume expansion. Samples
were obtained by microcatheterization during the 100-mm ex-
perimental period. Urine was collected at 20-mm intervals.
Samples of arterial blood (50 to 100 pJ) were taken at the mid-
point of each urine collection. Urine flow, sodium, and chloride
excretion varied by no more than 15% between clearance
periods and did not change significantly between the first and
last periods.
The three experimental groups consisted of: (1) volume
expansion controls (N = 8) which received the vehicle for
administration of indomethacin and meclofenamate 30 mm
before and immediately after opening the renal pelvis and
during the experiment; (2) indomethacin pretreated volume-
expanded rats (N = 8) which received indomethacin 5 mg/kg 30
mm before and 3 mg/kg just after opening the renal pelvis at the
rate of 0.05 mg/mm. A sustaining infusion of indomethacin (6
mg/kg/hr) was begun simultaneously with Ringer loading. Indo-
methacin was prepared for administration by dissolving 50 mg
in 0.5 ml of 0.5 M sodium carbonate, adding 2 ml of water
followed by 2.0 ml of 0.05 M hydrochloric acid and sufficient
Ringer's bicarbonate to yield the final concentration of 2.5 mg/
ml. (3) Meclofenamate pretreated volume-expanded rats (N =
8) received meclofenamate prepared in an identical vehicle and
administered in a dose of 3 mg/kg before and 3 mg/kg after
opening the renal pelvis at a rate of 0.03 mg/mm with a
sustaining infusion of 4 mg/kg/hr. These doses of indomethacin
and meclofenamate were selected because Higashihara et al [8]
have shown that urinary excretion of PGE2 and PGF2c. were
suppressed approximately 95% with either drug in similarly
volume-expanded rats subjected to anesthesia and micropunc-
ture.
The technique of sampling collecting duct fluid was used as
described previously [2]. Briefly, fine polyethylene catheters
(OD 16 to 20 p.m) were inserted to varying distances into
different collecting ducts via the exposed papilla tip. Whenever
possible three samples were obtained consecutively in the same
collecting duct system from near the papillary tip, at intermedi-
ate depth, and deep in the medulla. In each animal, 3 to 4 duct
systems were sampled (9 to 12 samples with 3 to 4 from each
depth), using controlled suction just sufficient to overcome the
tip resistance of the catheter. The depth of insertion of the
catheter was measured during withdrawal with a micrometer
and was related to medullary length obtained from a postmor-
tem sagittal section of the kidney.
At the end of the experiment, the renal papilla was removed
quickly and placed in a preweighed bottle. After determination
of the wet weight, the tissue was dried at 60° C for 48 hr and
reweighed for determination of water content. The tissue was
extracted with water at 80° C for 2 hr, and the chloride
concentration of this fluid was measured.
Sodium and potassium concentration in plasma and urine
were determined by flame photometry, and 3H-inulin concen-
tration was determined by liquid scintillation counting in tolu-
ene-based scintillant. Plasma, urine, and papillary tissue chlo-
ride were measured using a Radiometer chloridometer. Urinary
excretion of sodium (UNaV), potassium (UKV), and chloride
(Uc[V) were calculated, as was GFR. Sodium and potassium
concentrations in 10-ni portions of tubular fluid were measured
by helium glow photometry, chloride by chioridometry (W-P
Instruments Inc., New Haven, Connecticut), and 3H-inulin (30
nl) by liquid scintillation counting. A nanoliter osmometer
(Clifton Technical Physics, Hartford, Connecticut) measured
the total solute concentration in tubular fluid and urine samples.
For each tubular fluid sample, the fluid/plasma concentration
ratio of inulin (TF/P inulin) was determined and used to
calculate the fraction of filtered sodium (TF/PNa/TF/Pjflulifl),
potassium (TF/PK/TF/PIflUIIfl), and chloride (TF/Pc1/TF/P,1)
remaining at the collection site. Absolute loads of fluid and
electrolytes in the duct were calculated from the GFR of the
experimental kidney, plasma level, and remaining fraction of
filtered load (fractional delivery). The Student's t test was used
for statistical evaluation of paired samples near the beginning
(4.5 to 7.5 mm from tip), middle (2 to 4mm from tip), or end (0.1
to 1.0 mm from tip) of the medullary collecting duct. Compari-
sons between paired samples along the duct and between
groups were made using the Student's I test for paired and
unpaired samples, respectively. All values are shown as mean
I SEM.
Results
BP was significantly lower in the indomethacin pretreated
animals than in the volume expansion controls (MAP 109 3
vs. 126 4 mm.Hg, P < 0.01). BP in meclofenamate pretreated
animals was slightly but not significantly lower than in controls
(MAP 114 5 mm Hg). There were no significant differences
among the three groups in hematocrit, plasma sodium, potassi-
um, chloride, or osmolality.
Experimental kidney data. Glomerular filtration rate was not
significantly different among the three groups, while urine flow
rate was reduced by 59 and 64% in the indomethacin and
meclofenamate pretreated groups, respectively, compared to
the volume expansion controls (Table 1). Both urine sodium
and chloride excretion rates were reduced markedly in the
indomethacin and the meclofenamate pretreated animals com-
pared to controls (P < 0.001). The fraction of filtered sodium
excreted (FENa) was decreased from 5.03 0.36% in volume
expansion controls to 2.83 0.33% and 2.47 0.19% (P <
0.001) in indomethacin and meclofenamate pretreated groups,
respectively. The fractional excretion of chloride was reduced
similarly in the drug-treated groups. Urinary potassium excre-
tion was not affected by indomethacin or meclofenamate pre-
treatment. Urine osmolality increased from 360 14 mosm/kg
in volume expansion controls to 599 36 and 658 51 mosrn/
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Table 1. Glomerular filtration rate (GFR) and urinary excretion data in the experimental left kidney
Indomethacin and volume expansion
Length, inni
FRN:,%
FR,%
FRK%
TFo,a, mosm kgH2O
(N = 27)
5.53 0.13
5.83 0.88d
6.17 1.18
10.0 1.28
27.5 2.8
536 37'
(N — 27)
2.64 + 0.09
3.91 0.58
4.93 1.01
8.65 + 1.17
34.4 2.6
643 311
(N = 27)
0.56 + 0.04
NS 2.82 0.28
NS 2.98 0.271
NS 6.28 + 0.50d
NS 36.7 2.4
NS 661 38'
Abbreviations FRH,O, FRN,, FR,, FRK (%) refer to the fraction of filtered water, sodium, chloride, and potassium remaining at the indicated
point in the MCD.
a P indicates comparison of the beginning and mid-point; b midpoint and end; P beginning and end of the IMCD.
P < 0.02, compared to volume expansion controls.
P < 0.01, compared to volume expansion controls.
P < 0.001. compared to volume expansion controls.
Volume expansion controls
(N -8)
GFR Urine Flow(V) U,V
ml mm 'gkw p.1 miii 'gkw ' UNaV p.eq mm gkw'
6.33
0.33
<0.001
2.69
0.24
NS
FE0' FEN,, FEUKV % % mosm kgH2O
1.35 86.8 9.73 12.23 2.03
÷0.06 ÷0.16
P value" NS <0.001 <0.001 <0.001 NS
Indomethacin and volume
expansion (N = 8) 1.18 35.5 4.94 7.05 2.00
÷0.84 ÷0,26
Pvaluec NS NS NS NS NS
Meclofenamate and volume
expansion (N — 8) 1.31 31.2 4.75 6.76 1.63 2.350.24
P valued NS <0.001 <0.001 <0.001 NS <0.001
a Abbreviations are FEH,O. FENa, FEc,, — fractional excretion of filtered water, sodium, and chloride; UN,V, U V, UKV = urinary excretion
rate of sodium, chloride, and potassium.
Indomethacin and volume expansion compared to volume expansion controls.
Meclofenamate and volume expansion compared to indomethacin and volume expansion.
Meclofenamate and volume expansion compared to volume expansion controls.
Table 2. Inner medullary collecting duct (IMCD) function at the beginning, midpoint, and papillary tip (end) of the duct in three experimental
groups of rats
5.03
÷0.36
<0.001
2.83
NS
2.47
<0.001
8.37
÷056
<0.001
5.39
0.47
NS
4.63
÷0.27
<0.001
360
14
<0.001
599
36
NS
658
÷51
<0.001
Beginning(N — 30)
Length, rn/n
FR,J,O%
FRN,%
FR,%
FRK%
TFosm, mosm kgH2O
Volume expansion controls
5.51 +
9.03
6.12
9.78
30.4 +
326 ÷
0.17
0.71
0.57
0.80
2.6
18
Mid-point
(N — 30) P" End (N = 31) P
2.83
7.59
5.68
9.48
34.4
355
0.17
0.61
0.57
0.69
2.5
10
0.60
NS 7.18±
NS 5.42
NS 8.71
NS 37.0
NS 367
0.03
0.62
0.47
0.67
3.3
18
pa
NS
NS
NS
NS
NS
<0.001
NS
NS
<0.01
<0.01
<0.001
<0.001
<0.001
NS
<0.001
Meclofenamate and volume expan ion
(N — 30)
Length, mm 6.01 0.13
FRII,O% 7.48 1.01
FRNa% 5.75 0.77
FRc,% 10.17 + 1.38
FRK% 34.3 + 5.4
TFom, mosm kgH2O 414 22"
<0.05
NS
NS
NS
NS
<0.001
<0.02
<0.02
<0.001
<0.01
<0.001
<0.001
<0.001
NS
<0.001
(N - 31)
2.96 0.10
2.92 Ø,3Qf
2.60 O.l75.17 OW
33.3 2.4
659 38
(N — 32)
0.63 0.03
NS 3.10÷ 0.29'
NS 2.81 0.20
NS 5.60 0.30'
NS 37.7 2.5
NS 643 411
148 10 meq/liter in volume expansion controls to 238 28
meq/liter with indomethacin pretreatment (P < 0.01) and 202
24 meqfliter with meclofenamate pretreatment (P < 0.05).
kg (P < 0.001) in indomethacin and meclofenamate pretreated Collecting duct data
rats.
Papillary tissue chloride concentration was increased from Volume expansion controls. The sites of sampling from the
inner medullary collecting duct at the beginning, mid-point, and
papillary tip (end) are shown in Table 2, with the beginning and
end sampling sites separated by about 5 mm. The remaining
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Control Indo Meclo Control Indo Meclo
Fig. 2. Absolute loads of fluid, sodium, chloride, and potassium
delivered to the beginning and end of the medullary collecting duct in
three experimental groups. The asterisk indicates P < 0.001 comparing
end-MCD samples (E) from indomethacin or meclofenamate pretreated
groups with volume expansion controls. Beginning duct samples (B)
were not different in the three groups except for decreased fluid
delivery in the indomethacin-treated group (t = P < 0.01 compared to
controls). There were no differences in potassium transport among the
groups.
significantly along the duct (P < 0.02). The fractional delivery
of sodium and chloride at the beginning of the IMCD was not
different from controls, but the fraction remaining at the papil-
lary tip was significantly lower (P < 0.001 for FRNa and P <
0.02 for FRc1). These changes in collecting duct water and
sodium chloride reabsorption are shown in Figure 1. The
remaining fraction of filtered potassium (FRK) increased along
the duct, but the values were not different from volume
expansion controls.
Absolute loads of fluid and electrolytes at the beginning and
end of the duct in the three groups of animals are shown in
Figure 2. Fluid delivery to the duct was decreased by indometh-
acm, but sodium and chloride delivery, although slightly re-
duced, were not significantly different from volume expansion
controls. The fluid, sodium, and chloride loads remaining at the
papillary end of the duct were significantly less in indomethacin
pretreated animals, demonstrating collecting duct reabsorption.
The potassium load increased along the duct by a similar small
but significant amount in controls and indomethacin-treated
rats.
Meclofenamate and volume expansion. The remaining frac-
tion of filtered water, sodium, and chloride decreased markedly
between the beginning and end of the IMCD (P < 0.001, Table
2). It was of interest that these changes occurred principally
between the beginning and the midpoint of the duct (Fig. 1).
Fractional delivery to the duct was not different from volume
expansion controls, but the fraction remaining at the papillary
tip for water, sodium, and chloride were each markedly lower
than controls (P < 0.001). Tubular fluid osmolality increased
along the duct and was higher at each point than in controls.
The remaining fraction of filtered potassium did not change
along the duct. The absolute loads of fluid, sodium, and
chloride, at the beginning of the duct were similar to volume
expansion controls, but enhanced reabsorption along the duct
resulted in marked decrease in the load remaining at the end of
the duct in meclofenamate-treated rats compared to volume
expansion controls (Fig. 2). Potassium handling in the duct was
not different from the other two groups (Fig. 2).
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Fig. 1. Fractional remainder (±1 ,sEs1) of filtered fluid (upper panel
FRH,O), sodium, (middle panel FRNa), chloride (lower panel FR1) at
the beginning, midpoint, and end (papillary tip) of the medullarv
collecting duct (mean sampling site scM). The three experimental
groups are compared: volume expansion controls (0), indomethacin
and volume expansion (0), and meclofenamate and volume expansion
(s). The asterisk indicates P < 0.001 compared to same sampling site in
volume expansion controls.
fraction of filtered water decreased slightly but significantly
along the collecting duct. Tubular fluid osmolality increased
along the duct but the change was not statistically significant.
The remaining fraction of filtered sodium (FRNa), chloride
(FRc1), and potassium (FRK) did not change along the IMCD.
Indomethacin and volume expansion. When rats received
indomethacin prior to and during volume expansion, the re-
maining fraction of filtered water decreased markedly between
the beginning and end of the collecting duct (P < 0.001, Table
2). Both the fraction of filtered water delivered to the beginning
of the duct and the fraction remaining at the end were lower
than in volume expansion controls. Tubular fluid osmolality
increased along the duct from 536 37 to 661 38 mOsm/kg (P
< 0.01), both values being higher than in volume expansion
controls (P < 0.001). The major changes in water reabsorption
and osmolality occurred in the proximal portion of the duct,
between the beginning and midpoint. FRNC and FRc1 decreased
Chloride
—
15 - r-i
10 n. t.
HH_LI__
-1
Potassium
t:___
Fluid150
Sodium
6L DL DL
Abbreviations FR , FRNa, FR1 (%) refer to the fraction of filtered water, sodium, chloride remaining at the beginning and end of the inner
medullary collecting duct.
a Results were analyzed using the mean value for each animal.
b indicates comparison of beginning and end of IMCD (reabsorption).
P < 0.01, in comparison to volume expansion controls.
"P < 0.001, in comparison to volume expansion controls.
The collecting duct results also were analyzed using the mean
values for each animal; there were 3 to 4 samples at the
beginning, midpoint, and end of the duct in each experiment.
The differences in IMCD water, sodium, and chloride transport
between volume expansion controls and animals treated with
indomethacin and meclofenamate persisted using this analysis
and are summarized in Table 3. With meclofenamate there was
significant reabsorption along the duct, while with indometh-
acm the trend was the same, but reabsorption was not statisti-
cally significant because of greater scatter of the data. Compari-
son of the results in individual animals for the fractional
remainder of filtered sodium (FRNa%) is shown in Figure 3,
which indicates that the FRNa% is considerably lower at the end
of the duct during treatment with indomethacin (3.01 0.14%)
or meclofenamate (2.81 0.20%) compared to volume expan-
sion controls (5.39 0,68%, P < 0.02 and P < 0.001).
Discussion
The administration of either of two structurally dissimilar
inhibitors of pro staglandin synthesis, indomethacin and meclo-
fenamate, resulted in a marked reduction in the diuretic,
natriuretic, and chloriuretic response to extracellular fluid
volume expansion with isotonic Ringer's bicarbonate solution.
These results confirm the observations of other investigators
concerning the effects of inhibition of prostaglandin synthesis
on the whole kidney response to volume expansion [8—13]. To
localize within the nephron the effect of inhibition of prostaglan-
din production on the chloriuresis of acute volume expansion,
Higashihara et al [8] carried out micropuncture sampling of the
proximal and distal tubule of superficial nephrons, the loop of
Henle of deep nephrons, and the base and tip of the papillary
portion of the collecting duct. During inhibition of prostaglandin
synthesis, they observed an increase in chloride reabsorption in
the superficial ioop of Henle, similar fractional delivery to the
late distal tubule, increased reabsorption between the superfi-
cial late distal tubule and the base of the papillary collecting
duct, and no effect along the 1 to 2 mm terminal papillary duct.
The relative increase in chloride reabsorption between the
superficial late distal tubule and the papillary segment of the
collecting duct during inhibition of prostaglandin synthesis
could have been due to increased reabsorption in the cortical
and/or medullary collecting duct or to increased reabsorption in
the distal tubule of juxtamedullary nephrons. or to both.
,
.
.
'
B
0
I
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0
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8.0 6.0 4.0 2.0
Medullary length, mm
Fig. 3. Fraction of filtered sodium remaining at the beginning, mid-
point, and end of the medullary collecting duct in individual animals of
the three groups. Abbreviations are A, volume expansion controls (C);
B, indomethacin and volume expansion (LI); C, meclofenamate and
volume expansion (i). There were no differences between the three
groups at the beginning of the duct. Group C was lower than group A at
the midpoint (P < 0.00 1), and groups B and C were lower than group A
controls at the end of the duct, P < 0.02 and 0.001, respectively. In
group B, if the animal with highest fractional delivery is omitted,
delivery is less than in controls, P < 0.05.
The aim of this study was to further examine the changes in
renal electrolyte handling resulting from inhibition of prosta-
glandin synthesis during volume expansion in the rat by using
the microcatheterization technique to study the medullary
collecting duct, the nephron segment which extends for 7 to 9
mm from the corticomedullary junction to the papillary tip.
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Table 3. Comparison of fractional and absolute loads of water, sodium, and chloride at the beginning and end of the inner medullary collecting
duct in volume expansion controls and rats treated with the prostaglandin synthesis inhibitors (PGSI). indomethacin or meclofenamate"
Volume expansion controls (N = 8) Prostaglandin synthesis inhibitors (N 16)
Beginning End Beginning End
FRH2O%
FRNa%
9.04
6.08
0.91
0.78
7.15 0.71
5.39 0.68
<0.05
NS
6.71 1.13
5.92 0.11
2.97 024"
2.91 022d
<0.01
<0.02
FR1% 9.72 0.11 8.69 0.91 NS 10.2 0.15 6.00 0.39' <0.02
Fluid, p.l mm gkw ' 123.2 15.4 96.2 10.2 <0.05 84.6 15.2 37.4 3.7" <0.01
Sodium, p.1 mm ' gkw l 12.1 1.8 10.6 1.50 NS 10.6 + 1.8 5.28 0.43" <0.01
Chloride, p.1 min gkw ' 14.5 1.9 12.9 1.5 NS 14.0 2.0 8.29 0.59" <002
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Although several samples were obtained 7 to 8 mm from the
papilla tip, the average length of collecting duct studies was 5 to
6 mm, which comprises the IMCD.
Fluid reabsorption along the IMCD was detectable in vol-
ume-expanded controls (1.85% of filtered load, Table 2) but was
markedly enhanced in volume-expanded animals which were
pretreated with indomethacin or meclofenamate (3.01 and
4.38%, respectively). With indomethacin, the enhanced water
reabsorption was associated with a decrease in delivery of fluid
to the beginning of the duct (Fig. 2), while with meclofenamate
fluid delivery was decreased but the difference from control
values was not significant. Urine osmolality was increased
markedly with indomethacin and meclofenamate, and this in-
crease was the result of significant changes in tubular fluid
osmolality along the collecting duct as well as in the osmolality
of delivered fluid (Table 2). The increase in fluid reabsorption in
the IMCD and in more proximal nephron segments after
inhibition of prostaglandin synthesis is presumably due, at least
in part, to the known effects of prostaglandins to antagonize
ADH-dependent changes in water permeability [14, 15]. In
addition there is evidence that inhibition of prostaglandin
synthesis decreases blood flow to the deeper portions of renal
cortex [16] and renal medulla 1171, possibly contributing to an
increase in medullary interstitial solute concentration and hence
increased collecting duct water reabsorption. Chuang et al [18]
have shown that indomethacin or meclofenamate decreases
papillary blood flow and increases urine osmolality in the
hydropenic rat with an exposed papilla, although this effect was
not confirmed with meclofenamate in a recent study by Roman
and Lechene [19]. In this study, both indomethacin and meclo-
fenamate resulted in a significant increase in medullary tissue
chloride concentration in association with increased collecting
duct fluid reabsorption.
In contrast to the effects on water, sodium, and chloride
excretion and collecting duct reabsorption, there were no
differences in urinary potassium excretion (UKV, Table 1) and
collecting duct potassium handling between volume expansion
controls and the two groups pretreated with indomethacin and
meclofenamate (Table 2, Fig. 2). This finding is of interest in
view of the marked decrease in fluid flow rate and increase in
sodium chloride reabsorption with inhibition of prostaglandin
synthesis.
Medullary collecting duct reabsorption of sodium and chlo-
ride was not detectable in volume-expanded control animals, as
we have documented previously [2, 5]. Chloride reabsorption
was also not significant as noted before [6]. After pretreatment
with indomethacin or meclofenamate in two groups of animals,
fractional reabsorption of sodium was 3.19 and 2.94%, respec-
tively, and fractional reabsorption of chloride was 3.72 and
4.57% between the beginning and end of the medullary collect-
ing duct (Table 2, Fig. 1). Moreover, the changes in the
fractional reabsorption along the duct largely accounted for the
blunting of the whole kidney response to volume expansion,
because the absolute delivery of sodium and chloride to the
beginning of the medullary collecting duct was not significantly
decreased during inhibition of prostaglandin synthesis (Fig. 2).
Our finding of increased chloride reabsorption in the medul-
lary collecting duct during prostaglandin synthesis inhibition is
in agreement with the previous observations of an increase in
reabsorption between the superficial late distal tubule and base
of the papillary collecting duct [8]. Higashihara et at [8] con-
eluded that this enhanced reabsorption was probably due to a
selective effect of prostaglandin inhibition on juxtamedullary
nephron function. However, because all nephrons enter the
collecting ducts in the renal cortex prior to the beginning of the
medullary collecting duct [20, 21], our data provide direct
evidence that increased medullary collecting duct reabsorption
is largely responsible for the observed changes in sodium
chloride excretion during prostaglandin synthesis inhibition.
With meclofenamate the increase in fractional reabsorption of
fluid, sodium, and chloride, occurred largely in the proximal
portion of the collecting duct (Fig. 1), rather than in the 2 to 3
mm portion near the papillary tip (Fig. I). After indomethacin
pretreatment, increased sodium chloride reabsorption appeared
to occur along the length of the IMCD and, in addition, there
was a tendency (not significant) for delivery to the duct to be
reduced, suggesting that reabsorption in more proximal neph-
ron segments may have been enhanced as well. We did not
study changes in reabsorption in the terminal 1 mm or papillary
portion of the collecting duct, but Higashihara et al [8] observed
no effect of prostaglandin inhibition on this segment, and our
observations are compatible with this finding.
The finding of an effect of prostaglandin synthesis inhibition
on medullary collecting duct reabsorption is not surprising
because micropuncture studies of superficial nephrons have
localized the effect of PGE2 to beyond the distal tubule of the
rat [12, 22, 231. Moreover, studies of isolated rabbit renal
tubules in vitro have indicated that POE2 and PGF2. directly
inhibit sodium reabsorption across the cortical and outer medul-
lary collecting tubule of the rabbit [24, 25]. In the presence of
increased medullary interstitial chloride concentration in the
present study, enhanced sodium and chloride reabsorption is
most likely due to a direct effect of inhibition of prostaglandin
synthesis to enhance sodium and chloride reabsorption across
the medullary collecting duct.
Summary, The mechanism of inhibition of collecting duct
sodium and water reabsorption observed during acute volume
expansion has been unexplained previously. The results of this
study, whereby decreased prostaglandin synthesis returns wa-
ter and electrolyte reabsorption in the collecting duct toward
normal despite continued volume expansion, strongly suggest
that enhanced endogenous prostaglandin synthesis is an impor-
tant component of the response to volume expansion in the
collecting duct of the rat kidney. Enhanced prostaglandin
synthesis could mediate, in part, the diuretic response to
volume expansion either by increasing medullary blood flow
and dissipating the medullary interstitial counter current gradi-
ent or by antagonizing the effect of antidiuretic hormone in the
collecting duct, and could enhance natriuresis and chloriuresis
by directly reducing collecting duct sodium chloride
reabsorption.
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